Floating sidebar

"Science knows no country, because knowledge belongs to humanity, and is the torch which illuminates the world." - Louis Pasteur

Translate

Selected papers from the 46th ECDSA-2017 congress to be published in Molecules (IF = 2.47)


Instructions for registration for participation in the ECDSA-2017 congress:
https://sites.google.com/site/cfph2017/



Special Issue Information:

Dear Colleagues,

The 46th EuroCongress on Drug Synthesis and Analysis (ECDSA-2017) will be arranged within the celebration of the 65th Anniversary of the Faculty of Pharmacy at Comenius University in Bratislava, Slovakia. The congress will be held at the Faculty of Pharmacy in Bratislava, Slovakia on September 5–8, 2017.

The traditional symposium “Drug Synthesis and Analysis” has a long history. Over the last decade it has been transformed from a local Czech-Slovak symposium to an international conference, and now this prestigious international conference has become known as “EuroCongress on Drug Synthesis and Analysis“. These high-quality series of meetings cover all the fields of pharmaceutical sciences. The aim of ECDSA is to develop a platform for promoting cooperation between scientists sharing scientific interests in pharmaceutical/biomedical sciences from European and other countries and to support cooperation between scientists in this field. Excellent speakers from all over the world will present their results within individual sections of ECDSA-2017. For all details please see https://sites.google.com/site/cfph2017, where the full list of presenters is available, including Danica Agbaba, Marc Diederich, Norbert Haider, Yifan Han, Danijel Kikelj, Teresa Kowalska, Mark Olsen, Wei-Dong Pan, AndrĂ¡s Perczel, Robert C. Reynolds, Jerzy Silberring, Christian H. Zidorn and many others.

Participants of the conference are cordially invited to contribute original research papers or reviews to this Special Issue of Molecules.

Prof. Dr. Josef Jampilek, Ph.D.
Dr. Atanas G. Atanasov, Ph.D.
Guest Editors


Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


Keywords:
Drug design, research and development
Drug formulations and drug delivery systems
Structure, function and interactions of proteins
Natural compounds
Structural analysis
Solid state analysis
Electrochemistry
Chiral compounds
Chemical biology
Biological chemistry
Engineered enzymes
Nucleic acids chemistry
Targeting
Biomaterials
Nanomaterials
Pharmacology and ADME


Access to the special issue website and additional information:
http://www.mdpi.com/journal/molecules/special_issues/ECDSA2017


Webmaster:

Prof. Atanas G. Atanasov (Dr. habil., PhD)
https://about.me/Atanas_At


No comments:

Post a Comment